Protara Therapeutics TARA
NASDAQ TARA
$2.70 -0.06 (-2.17%)
At close: Oct 2, 2026 · 4:00 PM EDT

Protara Therapeutics (TARA) Return on Capital Employed [ROCE] (2014 - 2026)

Updated

Protara Therapeutics' Return on Capital Employed [ROCE] came in at -44.99% for Q2 2026, down 7.50 percentage points from -37.49% a year earlier and down 8.46 percentage points from the prior quarter.

Analysis

Protara Therapeutics (TARA) Return on Capital Employed [ROCE] (2014 - 2026) Analysis & Trends

For FY2025, Protara Therapeutics' Return on Capital Employed [ROCE] was -34.98%, up 6.24 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has increased in each of the last three years, though with a five-year change of -0.29 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -41.22% in FY2024 (+7.25 pp), -48.47% in FY2023 (+0.40 pp), -48.88% in FY2022 (-23.01 pp) and -25.87% in FY2021 (+8.83 pp).
  • The Q2 2026 figure represents the lowest quarterly Return on Capital Employed [ROCE] since Q3 2024.
  • Year-over-year, Return on Capital Employed [ROCE] has declined for three consecutive quarters, with an average year-over-year change of +12.66 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q1 2025 (a gain of 36.60 percentage points), and the weakest in Q3 2023 (a drop of 59.21 percentage points).
  • Business Quant data shows TARA's Return on Capital Employed [ROCE] at -36.53% (Q1 2026), -38.86% (Q4 2025) and -42.44% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Protara Therapeutics 159.53 Mn 159.53 Mn - -44.99%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -44.99%
Mar 31, 2026 -36.53%
Dec 31, 2025 -38.86%
Sep 30, 2025 -42.44%
Jun 30, 2025 -37.49%
Mar 31, 2025 -30.61%
Dec 31, 2024 -38.76%
Sep 30, 2024 -51.42%
Jun 30, 2024 -55.85%
Mar 31, 2024 -67.21%
Dec 31, 2023 -56.23%
Sep 30, 2023 -84.77%
Jun 30, 2023 -72.36%
Mar 31, 2023 -63.73%
Dec 31, 2022 -53.56%
Sep 30, 2022 -25.56%
Jun 30, 2022 -26.33%
Mar 31, 2022 -27.30%
Dec 31, 2021 -27.55%
Sep 30, 2021 -25.49%
API Access

Protara Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=TARA&period=max&api_key=YOUR_API_KEY